Kelly Stevens


Our goal is to hijack and rewire aspects of nature's developmental programs to control the processes by which cells assemble to form human tissues. We are also working to develop technologies to remotely control these tissues after implantation in a patient. To do this, we use diverse tools from stem cell biology, tissue engineering, synthetic biology, microfabrication, and bioprinting. We seek to translate our work into new regenerative therapies for patients with heart and liver disease.